☆ 4.7 Article

scFv biofunctionalized nanoparticles to effective and safe targeting of CEA-expressing colorectal cancer cells

JOURNAL OF NANOBIOTECHNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Chemistry, Medicinal

5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy

Anai A. Valencia-Lazcano et al.

Summary: This study reviews the applications of 5-Fluorouracil (5-FU) as an anticancer drug for various types of cancers. Different approaches, such as nanoparticles loaded with 5-FU, co-delivery systems with other drugs, have been described to overcome the limitations of 5-FU therapy. This review provides the latest progress on 5-FU-loaded nanocarriers and their potential as an advanced tool for cancer therapy.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Add to Collection

Article Oncology

Colorectal cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: Colorectal cancer is the second leading cause of cancer death in the United States. The incidence of CRC has slowed down, but it is shifting to a younger age, advanced stage, and left colon/rectum. Mortality from CRC has declined overall, but increased in individuals younger than 50 years and Native Americans younger than 65 years. Uncovering the reasons for rising incidence and improving access to screening and treatment are crucial in combating CRC.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Add to Collection

Article Chemistry, Multidisciplinary

Stimuli-Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood-to-Brain Trafficking and Tumor Targeting

Claudia Martins et al.

Summary: Report the development of hypothesis-driven stimuli-responsive nanoparticles (NPs) for glioblastoma (GBM) therapy. These NPs have multifunctional features that overcome the insufficient blood-brain barrier (BBB) trafficking and lack of GBM targeting, two major challenges in anti-GBM treatments. In preclinical studies, the stimuli-responsive NPs effectively targeted GBM cells, enhanced cell uptake, increased cytotoxicity, improved BBB permeability, and demonstrated antitumor efficacy in GBM models.

SMALL (2023)

Add to Collection

Article Multidisciplinary Sciences

Clinical implication of tissue carcinoembryonic antigen expression in association with serum carcinoembryonic antigen in colorectal cancer

Abdulmohsin Fawzi Aldilaijan et al.

Summary: This study aimed to evaluate the prognostic significance of carcinoembryonic antigen (CEA) expression in tumor tissues of patients with colorectal cancer (CRC). The study found that high expression of CEA was significantly associated with poorer disease-free survival and overall survival rates. High-intensity t-CEA was identified as an important prognostic factor in CRC, independent of serum CEA, and can complement the use of serum CEA in predicting survival outcomes after CRC resection.

SCIENTIFIC REPORTS (2023)

Add to Collection

Article Pharmacology & Pharmacy

PLGA/PEG Nanoparticles Loaded with Cyclodextrin-Peganum harmala Alkaloid Complex and Ascorbic Acid with Promising Antimicrobial Activities

Sherif Ashraf Fahmy et al.

Summary: This study successfully improved the water solubility and bioavailability of harmala alkaloids using a complex and nanoparticle approach, and demonstrated high antibacterial and antiviral activity.

PHARMACEUTICS (2022)

Add to Collection

Review Oncology

Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis

Sanne ten Hoorn et al.

Summary: The CMS classification system has potential clinical value in predicting prognosis and treatment response in colorectal cancer (CRC) patients. In local disease, CMS4 tumors have worse overall survival, while in metastatic disease, CMS1 tumors consistently have worse survival. Adjuvant chemotherapy is most beneficial for CMS2 and CMS3 tumors in stage II and III CRC, while it is not effective in CMS4 tumors.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

Add to Collection

Review Pharmacology & Pharmacy

PLGA-Based Nanomedicine: History of Advancement and Development in Clinical Applications of Multiple Diseases

Hashem O. Alsaab et al.

Summary: Research on the use of biodegradable polymers for drug delivery, particularly PLGA, has been ongoing for several decades. PLGA, a family of FDA-approved biodegradable polymers, possesses high biocompatibility and tunability. This paper explores the manufacturing processes, characteristics, and applications of PLGA in drug release.

PHARMACEUTICS (2022)

Add to Collection

Review Biotechnology & Applied Microbiology

Recent advances in PLGA micro/nanoparticle delivery systems as novel therapeutic approach for drug-resistant tuberculosis

Liqun Shao et al.

Summary: This study systematically reviewed the recent advances in PLGA micro/nanoparticle delivery systems as a novel therapeutic approach for drug-resistant tuberculosis.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

Add to Collection

Article Biology

Genetic and microenvironmental intra-tumor heterogeneity impacts colorectal cancer evolution and metastatic development

Daniel Sobral et al.

Summary: This study analyzes the genetic and microenvironmental heterogeneity of colorectal cancer using a prospective biobank of primary and metastatic tumor tissues to highlight features of intra-tumoral heterogeneity that favor tumor progression and metastasis.

COMMUNICATIONS BIOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Emerging new therapeutic antibody derivatives for cancer treatment

Shijie Jin et al.

Summary: This review article introduces the potential of monoclonal antibodies as targeted anticancer agents and their applications in cancer therapy. It also discusses various types of antibodies, clinical study advances, and the rationale and mechanisms of different antibody formats. Well-designed novel antibodies are paving the way for successful treatments of various cancers in the clinic.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Add to Collection

Article Multidisciplinary Sciences

Three dimensional cultivation increases chemo- and radioresistance of colorectal cancer cell lines

Jana Koch et al.

Summary: The study demonstrates that 3D cell cultures exhibit higher resistance to radiation therapy and certain chemotherapeutic drugs compared to 2D cell cultures, underscoring the importance of considering these differences in future approaches to modeling human diseases.

PLOS ONE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

5-Fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING

Jingru Tian et al.

Summary: 5-FU reduces tumor burden by triggering anti-tumor immunity through activating cancer-cell-intrinsic STING, which requires the involvement of cGAS and interferons. The presence of T cells is also crucial for the efficacy of 5-FU treatment.

EMBO JOURNAL (2021)

Add to Collection

Article Oncology

Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines

Tomonari Suetsugu et al.

Summary: Fluorouracil (5FU) is converted to its active metabolite fluoro-deoxyuridine monophosphate (FdUMP) through different pathways in different cells, contributing to varying mechanisms of resistance. When overcoming 5FU resistance, both the synthesized amount of FdUMP and sensitivity to FdUMP should be taken into consideration.

ONCOLOGY REPORTS (2021)

Add to Collection

Review Medicine, Research & Experimental

5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition

Chinmayee Sethy et al.

Summary: 5-Fluorouracil (5-FU) is a crucial anti-cancer drug, but drug resistance has hindered its clinical efficacy. Overcoming chemoresistance, especially caused by cancer stem cells, remains a challenge.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection

Review Pathology

Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer

Kate Wilkinson et al.

Summary: The immune landscape within and around tumors plays a crucial role in cancer development and response to therapy in colorectal cancer. Studies have shown that a type 1 adaptive immune response in the tumor immune microenvironment is associated with better prognosis. Efforts are needed to develop predictive biomarkers rather than prognostic ones to improve patient outcomes, especially in guiding cytotoxic chemotherapy use which remains the standard of care. Immune markers have the potential to serve as useful predictive biomarkers but are currently under-reported.

JOURNAL OF CLINICAL PATHOLOGY (2021)

Add to Collection

Review Oncology

Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach

Guillermo Valenzuela et al.

Summary: The identification of genetic mutations in CRC has led to the development of CMS, a classification system that categorizes patients into four molecular subtypes. This classification can help provide personalized treatment options for CRC patients by addressing specific genetic and molecular characteristics.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis

Hui Wang et al.

Summary: Colorectal cancer (CRC) is a highly prevalent and lethal malignant tumor in the digestive system. Tumor-associated macrophages (TAMs) play a crucial role in various mechanisms of CRC progression, such as promoting tumor proliferation, invasion, angiogenesis, and immunosuppression, although their exact role is still debated in clinical evidence.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Chemistry, Multidisciplinary

p28-functionalized PLGA nanoparticles loaded with gefitinib reduce tumor burden and metastases formation on lung cancer

Ana Rita Garizo et al.

Summary: The study developed a novel GEF delivery system by functionalizing PLGA nanoparticles with the cell-penetrating peptide p28 derived from bacterial protein azurin, which selectively reduced the metabolic activity of A549 lung cancer cells while sparing non-tumor cells. In vivo studies using A549 subcutaneous xenograft demonstrated that p28-NPs-GEF effectively reduced primary tumor burden and lung metastases formation, suggesting a promising new strategy to improve lung cancer therapy.

JOURNAL OF CONTROLLED RELEASE (2021)

Add to Collection

Article Genetics & Heredity

Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer

Peter W. Eide et al.

Summary: Gene expression-based subtypes of colorectal cancer have clinical significance, but the representativeness of primary tumors and consensus molecular subtypes (CMS) for metastatic cancers remains unclear. Metastases exhibit decreased CMS1/CMS3 signals and increased CMS4 signals, influenced by the microenvironment. The majority of classified metastases are CMS2 or CMS4, with subtype switching and inter-metastatic CMS heterogeneity being common.

NPJ GENOMIC MEDICINE (2021)

Add to Collection

Review Chemistry, Multidisciplinary

Cytotoxicity of targeted PLGA nanoparticles: a systematic review

Hock Ing Chiu et al.

Summary: Recent advancements in nanotechnology have significantly advanced the development of drug delivery systems in nanomedicine, with a focus on PLGA nanoparticles. However, concerns remain regarding their efficacy against cancer cells and toxicity to normal cells. This systematic review suggests that smaller PLGA nanoparticles exhibit higher cytotoxic potency, with sizes predominantly below 300 nm and zeta potentials around 20 mV. Comprehensive evaluations involving pharmacokinetic, toxicokinetic, in vivo and in vitro tests are needed to fully understand the potential of PLGA nanoparticles for cancer treatment.

RSC ADVANCES (2021)

Add to Collection

Review Materials Science, Biomaterials

Immunomodulatory nanomedicine for colorectal cancer treatment: a landscape to be explored?

Maria Jose Silveira et al.

Summary: Colorectal cancer (CRC) is one of the deadliest cancers in the world, mainly due to metastasis events. The immunosuppressive tumor microenvironment (TME) plays a key role in tumorigenesis and disease progression. Utilizing nanotechnology for the development of immunomodulatory therapeutic strategies shows potential in controlling TME and inhibiting tumor progression.

BIOMATERIALS SCIENCE (2021)

Add to Collection

Review Polymer Science

The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation

Thai Thanh Hoang Thi et al.

POLYMERS (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

Strategies to Obtain Encapsulation and Controlled Release of Small Hydrophilic Molecules

Qi Li et al.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)

Add to Collection

Review Oncology

5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes

Sabrina Blondy et al.

CANCER SCIENCE (2020)

Add to Collection

Article Nanoscience & Nanotechnology

Recent Advances in Designing 5-Fluorouracil Delivery Systems: A Stepping Stone in the Safe Treatment of Colorectal Cancer

Elaheh Entezar-Almahdi et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)

Add to Collection

Meeting Abstract Oncology

Molecular markers of response to different chemotherapeutic agents in RAS / BRAF mutated colon cancer cell lines

K. Doello et al.

ANNALS OF ONCOLOGY (2020)

Add to Collection

Review Materials Science, Biomaterials

Phenomenology of the Initial Burst Release of Drugs from PLGA Microparticles

Jin Yoo et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)

Add to Collection

Article Nanoscience & Nanotechnology

In vivo Bio-Distribution and Toxicity Evaluation of Polymeric and Lipid-Based Nanoparticles: A Potential Approach for Chronic Diseases Treatment

Joao Fonseca-Gomes et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

M2 macrophages confer resistance to 5-fluorouracil in colorectal cancer through the activation of CCL22/PI3K/AKT signaling

Chen Wei et al.

ONCOTARGETS AND THERAPY (2019)

Add to Collection

Article Oncology

CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids

Reyes Gonzalez-Exposito et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

Add to Collection

Article Oncology

Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil associated chemoresistance in colorectal cancer cells

Aki Sakatani et al.

CARCINOGENESIS (2019)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer models

Fortune M. K. Elekonawo et al.

EJNMMI RESEARCH (2019)

Add to Collection

Article Medicine, Research & Experimental

Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer activity and ameliorates side effects in solid Ehrlich Carcinoma-bearing mice

Yusuf A. Haggag et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Add to Collection

Review Materials Science, Biomaterials

Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics

Dawei Ding et al.

MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2018)

Add to Collection

Article Engineering, Biomedical

The effect of surface poly(ethylene glycol) length on in vivo drug delivery behaviors of polymeric nanoparticles

Ji-Long Wang et al.

BIOMATERIALS (2018)

Add to Collection

Article Pharmacology & Pharmacy

Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil

Mazen M. El-Hammadi et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies

Kaja C. G. Berg et al.

MOLECULAR CANCER (2017)

Add to Collection

Article Oncology

Novel anticarcinoembryonic antigen antibody-drug conjugate has antitumor activity in the existence of soluble antigen

Daisuke Shinmi et al.

CANCER MEDICINE (2017)

Add to Collection

Article Oncology

Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer

Alberto Malesci et al.

ONCOIMMUNOLOGY (2017)

Add to Collection

Article Biochemistry & Molecular Biology

The consensus molecular subtypes of colorectal cancer

Justin Guinney et al.

NATURE MEDICINE (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y1086, c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity

A. P. Cardoso et al.

ONCOGENE (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Expression and structural characterization of anti-T-antigen single-chain antibodies (scFvs) and analysis of their binding to T-antigen by surface plasmon resonance and NMR spectroscopy

Noriyuki Yuasa et al.

JOURNAL OF BIOCHEMISTRY (2013)

Add to Collection

Article Engineering, Biomedical

Nanoparticles functionalised with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells

Kim L. Vigor et al.

BIOMATERIALS (2010)

Add to Collection

Article Oncology

Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability

Michael M. Schmidt et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)

Add to Collection

Article Oncology

Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroids

Margaret E. Ackerman et al.

MOLECULAR CANCER THERAPEUTICS (2008)

Add to Collection

Article Biochemistry & Molecular Biology

Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37°C

CP Graff et al.

PROTEIN ENGINEERING DESIGN & SELECTION (2004)

Add to Collection

Article Biochemistry & Molecular Biology

Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy

YC Lee et al.

JOURNAL OF MOLECULAR BIOLOGY (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.